Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trial

Table 2 Content of education in patients or patient representatives who received education at first dispensing

	Experimental group (N= 72)	Control group (N= 78)	P-value
Patient himself/herself fetched medication and was interested	49 (68.1)	47 (60.3)	0.323
Patient label read out loud ^a;b	62 (86.1)	54 (69.2)	0.017
Importance of long-term use ^a	53 (73.6)	47 (60.3)	0.098
Indication of the statin	56 (77.8)	46 (59.0)	0.016
How statin works	44 (61.1)	45 (57.7)	0.661
Side effects	47 (65.3)	48 (61.5)	0.636
What to do when a dose intake is missed	20 (27.8)	24 (30.8)	0.577
Interactions	20 (27.8)	27 (34.6)	0.352
Contact for more information	33 (45.8)	36 (46.2)	0.931
At least one of these	65 (90.3)	55 (70.5)	0.006
Both subjects which were recommended in protocol EAFD	51 (70.8)	47 (60.3)	0.179

EAFD, education at first dispensing
Data are absolute frequencies, with the percentage between brackets.
^a Recommended in the protocol for education at first dispensing
^b The patient label includes information on the name, strength and use of the statin.

ISSN: 1472-6963